Torrent Pharma sheds nearly 7% after USFDA sends warning letter for Gujarat facility
Updated : October 10, 2019 09:50 AM IST
Torrent Pharma received a warning letter from USFDA for the Indrad facility in Gujarat.
The stock fell as much as 6.7 percent to Rs 1,554.65 per share on BSE.
Have you signed up for Primo, our daily newsletter?It has all the stories and data on the market, business, economy and tech that you need to know.
THANK YOU! You made our day. See you every morningYOUR EMAIL IS ON ITS WAY. Check your inbox for future updates.
To keep watching CNBC-TV18, India's No. 1 English Business News Channel, call your Cable or DTH Operator and subscribe now for just Rs. 4 per month. You can also subscribe to CNBC-TV18 Prime HD for Re 1/- per month.Find out more